HOME >> MEDICINE >> NEWS
Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer

Working with human colorectal cancer cells, a University of Minnesota team, led by cancer biologists Zigang Dong and Ann Bode, has found the potential culprit among a network of enzymes that relay signals inside cells to regulate such functions as cell growth, cancer development and programmed cell death. The work suggests that drugs designed to disable the enzyme, known as TOPK, could have anti-cancer benefits. The study appears in the July issue of the journal Gastroenterology.

Colorectal [cancer] is the second leading cause of cancer mortality, and the molecular pathways [by which it develops] remain incompletely understood, said Dong, a McKnight Presidential Professor in cancer prevention and director of the universitys Hormel Institute in Austin, Minn. In this study, we provided evidence showing that TOPK promotes transformation [of normal cells to cancerous ones] in colorectal carcinoma.

The story begins with the frequent observation by researchers that members of this enzyme network are overactive in the cells of several human cancers. The function of all these enzymes is to activate other enzymes and proteins, which makes them ideal for passing along signals.

For example, a cancer-causing agent or a hormone may find its way from the bloodstream to the outer membrane of a cell. After its arrival, it sets off a chain of reactions, or signals, inside the cell. Some of these signals take the form of certain enzymes activating others. Eventually, the news reaches the genetic material inside the cell nucleus, where changes resulting in uncontrolled growth--cancer--or some other cell behavior are made.

It was thought that some form of an enzyme called MEK, which belongs to the family of signaling enzymes, was the culprit. But to cause cancer, an enzyme or other agent is expected to be active all the time, like a light with no off switch. MEK, however, is never active all the time in nature; only if kept artificially activ
'"/>

Contact: David Ruth
druth@umn.edu
612-624-1690
University of Minnesota
31-Jul-2007


Page: 1 2

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
8. Study outlines how stroke, head injury can increase risk of Alzheimers disease
9. Study identifies new regulator of fat metabolism
10. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
11. Study examines characteristics of female high school students who report steroid use

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/11/2019)... ... November 11, 2019 , ... ... primary care and occupational medicine, is expanding its long-term partnership with 919 ... engage franchise candidates. With more than 200 locations across the country, American Family ...
(Date:11/11/2019)... (PRWEB) , ... November 11, 2019 , ... Dr. John ... Department of Health and Human Services’ (HHS) Pain Management Best Practices Task Force (Pain ... , This meeting was in follow up to the HHS Pain Task Force’s final ...
(Date:11/9/2019)... ... November 08, 2019 , ... The Women’s Dermatologic Society (WDS) announced ... concerns. The WDS Board of Directors appointed Molly Hinshaw, MD to fill the remainder ... March 2019-March 2020 term and will be presented to the membership as the 2020-2021 ...
(Date:11/9/2019)... ... November 08, 2019 , ... Mount Sinai Medical-Legal Partnership (MSMLP), ... two initiatives that provide free special education law and advocacy assistance to families and ... Sinai that also honored the work of contributions of Blaine (“Fin”) Fogg, who was ...
(Date:11/7/2019)... ... ... Atlantic Ultraviolet Corporation makes it their business to fight the flu. The first ... season starts in October until March, Atlantic Ultraviolet makes it a point to host ... get their shot. , Ann Wysocki, COO of Atlantic Ultraviolet Corporation® says, “Atlantic Ultraviolet ...
Breaking Medicine News(10 mins):
(Date:11/11/2019)... ... 10, 2019 , ... A gifted actor and generous philanthropist, Laurence Fishburne, will ... an episode of "Behind The Scenes." The growth of health management tools in health ... staff. This segment will focus on which tools are the most successful in allowing ...
(Date:11/9/2019)... ... November 08, 2019 , ... As part ... sets aside a day to help raise awareness and improve diagnosis of a ... Unlike some forms of PH, CTEPH has several treatment options, including a potentially ...
(Date:11/9/2019)... ... November 09, 2019 , ... “Strong, silent” types ... hallmark of much-loved, fictional British characters, like James Bond and Sherlock Holmes, and, ... admire about calm stoicism, even in the most perilous and dire of situations? ...
Breaking Medicine Technology:
Cached News: